2020擭乮椷榓俀擭乯

榑暥

1.	Neurofibromatosis type 1 without cutaneous neurofibromas: a rare genotype-phenotype correlation? Hida T, Idogawa M, Ishikawa A, Mizukami M, Kato J, Sumikawa Y, Okura M, Tokino T, Uhara H. Eur J Dermatol. 2020 Oct 1;30(5):608-609. doi: 10.1684/ejd.2020.3861. PMID: 33185534 No abstract available.
2.	Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction. Iwaya T, Endo F, Takahashi F, Tokino T, Sasaki Y, Nishizuka SS. Gastroenterology. 2021 Jan;160(1):463-465.e4. doi: 10.1053/j.gastro.2020.09.035. Epub 2020 Oct 2. PMID: 33011175 No abstract available.
3.	Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs. Udagawa C, Sasaki Y, Tanizawa Y, Suemizu H, Ohnishi Y, Nakamura Y, Tokino T, Zembutsu H. PLoS One. 2020 Sep 28;15(9):e0239614. doi: 10.1371/journal.pone.0239614. eCollection 2020. PMID: 32986753 Free PMC article.
4.	Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy. Yoshimoto Y, Sasaki Y, Murata K, Noda SE, Miyasaka Y, Hamamoto J, Furuya M, Hirato J, Suzuki Y, Ohno T, Tokino T, Oike T, Nakano T. Gynecol Oncol. 2020 Nov;159(2):546-553. doi: 10.1016/j.ygyno.2020.08.020. Epub 2020 Sep 18. PMID: 32951893
5.	Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report. Ishiguro K, Sasaki Y, Takagi Y, Niinuma T, Suzuki H, Tokino T, Hayashi T, Takahashi T, Igarashi T, Matsuno Y. Medicine (Baltimore). 2020 Aug 28;99(35):e21938. doi: 10.1097/MD.0000000000021938. PMID: 32871937 Free PMC article.
6.	Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas. Ota R, Sawada T, Tsuyama S, Sasaki Y, Suzuki H, Kaizaki Y, Hasatani K, Yamamoto E, Nakanishi H, Inagaki S, Tsuji S, Yoshida N, Doyama H, Minato H, Nakamura K, Kasashima S, Kubota E, Kataoka H, Tokino T, Yao T, Minamoto T. J Pathol. 2020 Nov;252(3):330-342. doi: 10.1002/path.5529. Epub 2020 Sep 12. PMID: 32770675 Free PMC article.
7.	Interactive Web-based Graphs of Coronavirus Disease 2019 Cases and Deaths per Population by Country. Idogawa M, Tange S, Nakase H, Tokino T. Clin Infect Dis. 2020 Jul 28;71(15):902-903. doi: 10.1093/cid/ciaa500. PMID: 32339228 Free PMC article.
8.	Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Yokose T, Kitago M, Matsuda S, Sasaki Y, Masugi Y, Nakamura Y, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Yusuke F, Nakano Y, Endo Y, Abe K, Tokino T, Kitagawa Y. Cancer Sci. 2020 Jun;111(6):2174-2182. doi: 10.1111/cas.14425. Epub 2020 May 30. PMID: 32314446 Free PMC article.
9.	Genetic analyses of mosaic neurofibromatosis type 1 with giant cafe-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi. Hida T, Idogawa M, Okura M, Sugita S, Sugawara T, Sasaki Y, Tokino T, Yamashita T, Uhara H. J Dermatol. 2020 Jun;47(6):658-662. doi: 10.1111/1346-8138.15327. Epub 2020 Apr 4. PMID: 32246533
10.	Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum. Nakanishi H, Sawada T, Kaizaki Y, Ota R, Suzuki H, Yamamoto E, Aoki H, Eizuka M, Hasatani K, Takahashi N, Inagaki S, Ebi M, Kato H, Kubota E, Kataoka H, Takahashi S, Tokino T, Minamoto T, Sugai T, Sasaki Y. PLoS One. 2020 Feb 24;15(2):e0229262. doi: 10.1371/journal.pone.0229262. eCollection 2020. PMID: 32092099 Free PMC article.
11.	Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH). Idogawa M, Hida T, Tanaka T, Ohira N, Tange S, Sasaki Y, Uhara H, Masumori N, Tokino T, Natori H. Cancer Biol Ther. 2020 Apr 2;21(4):315-319. doi: 10.1080/15384047.2019.1702406. Epub 2019 Dec 17. PMID: 31847710 Free PMC article.
12.	Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients. Ogi K, Kobayashi J, Nakagaki T, Okamoto J, Koike K, Hirokawa N, Someya M, Sakamoto H, Takada K, Tokino T, Sasaki Y, Hiratsuka H, Miyazaki A. Oral Oncol. 2020 Mar;102:104509. doi: 10.1016/j.oraloncology.2019.104509. Epub 2019 Dec 12. PMID: 31839407 No abstract available.
13.	p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53. Suzuki N, Idogawa M, Tange S, Ohashi T, Sasaki Y, Nakase H, Tokino T. Oncogene. 2020 Mar;39(10):2202-2211. doi: 10.1038/s41388-019-1133-7. Epub 2019 Dec 11. PMID: 31827232
14.	Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis. Fujita Y, Matsuda S, Sasaki Y, Masugi Y, Kitago M, Yagi H, Abe Y, Shinoda M, Tokino T, Sakamoto M, Kitagawa Y. Cancer Sci. 2020 Feb;111(2):739-748. doi: 10.1111/cas.14268. Epub 2020 Jan 15. PMID: 31799787 Free PMC article.

妛夛敪昞

1. 堜屗愳 夒巎, 楅栘 嵷揈, 扥壓 惓堦榊, 帪栰 棽帄丂p53昗揑堚揱巕ARVCF偼僗僾儔僀僔儞僌曄壔偵傛傝p53偺庮釃梷惂擻傪曗彆偡傞丂戞79夞擔杮娻妛夛妛弍憤夛丆2020擭10寧丆峀搰丏
2. 扥壓 惓堦楴, 堜屗愳 夒巎, 帪栰 棽帄丂僩儕僾儖僱僈僥傿僽擕娻偵偍偗傞梊屻儅乕僇乕岓曗偲偟偰偺CPIG7.2偺摿掕丂戞1夞擔杮娻妛夛庒庤偺夛, 2020擭2寧, 擬奀.
3. 扥壓 惓堦楴, 堜屗愳 夒巎, 帪栰 棽帄丂梊屻晄椙側鋁憻偑傫偵偍偗傞忋旂儅乕僇乕偲偺娭楢偺帵嵈偝傟傞怴婯堚揱巕偺摿掕丂2020擭搙愭抂儌僨儖摦暔巟墖僾儔僢僩僼僅乕儉庒庤巟墖媄弍島廗夛丂2020擭9寧, 僆儞儔僀儞.
4. 扥壓 惓堦楴, 堜屗愳 夒巎, 帪栰 棽帄丂梊屻晄椙鋁憻偑傫偺儅乕僇乕岓曗偲側傞怴婯忋旂摿堎揑堚揱巕偺摿掕丂戞79夞擔杮娻妛夛妛弍憤夛,2020擭10寧,峀搰.
5. 彫愹 徆戙, 堜屗愳 夒巎, 扥壓 惓堦楴, 帪栰 棽帄丂挿嵔旕僐乕僪RNA lncAC1偼戝挵娻偵偍偄偰娻嵶朎偺憹怋傪懀恑偟傾億僩乕僔僗桿摫傪梷惂偡傞丂戞43夞擔杮暘巕惗暔妛夛擭夛,丂2020擭12寧, 僆儞儔僀儞.
6. 杒搱 梞巙, 娵嶳 楁弿, 崅郪 孾, 怴徖 栆, 嶳杮 塸堦榊, 峛斻 惓峀, 帪栰 棽帄, 彫嶳撪 惤, 拠悾 桾巙, 楅栘 戱 枬惈堓墛偍傛傃堓偑傫偵娭楢偡傞挿嵔non-coding RNA偺摨掕丂戞79夞擔杮娻妛夛妛弍憤夛丆2020擭10寧丆峀搰丏
7. 杒搱 梞巙, 娵嶳 楁弿 ,崅郪 孾, 怴徖 栆, 嶳杮 塸堦榊, 峛斻 惓峀, 帪栰 棽帄, 彫嶳撪 惤, 拠悾 桾巙, 楅栘 戱 枬惈堓墛偍傛傃堓偑傫偵娭楢偡傞挿嵔non-coding RNA偺摨掕丂戞43夞擔杮暘巕惗暔妛夛擭夛,丂2020擭12寧, 僆儞儔僀儞.
8. 郪揷 晲, 嵅乆栘 懽巎, 懢揷 椇夘, 捗嶳 隳, 敧旜 棽巎, 拞惣 岹壚, 嶳杮 塸堦榊, 媣曐揷 塸巏, 曅壀 梞朷, 楅栘 戱, 帪栰 棽帄, 尮 棙惉 旕擕摢廫擇巜挵態庮丄擲枌撪娻偵偍偗傞僎僲儉丒僄僺僎僲儉偺摑崌夝愅丂戞79夞擔杮娻妛夛妛弍憤夛丆2020擭10寧丆峀搰丏

尋媶彆惉

1. 帪栰棽帄丏p53宱楬偺攋抅偵傛傞庮釃埆惈壔偺夝柧偲暘巕昗揑帯椕傊偺墳梡丏暯惉31-椷榓俁擭搙暥晹壢妛徣壢妛尋媶旓曗彆嬥乮婎斦尋媶俠乯尋媶戙昞丏
2. 帪栰棽帄丆嵅乆栘懽巎丆堜屗愳夒巎丆扥壓惓堦楴丏乽愭恑僎僲儉夝愅尋媶悇恑僾儔僢僩僼僅乕儉乿丂暯惉28-椷榓俁擭搙暥晹壢妛徣壢妛尋媶旓曗彆嬥乮怴妛弍椞堟尋媶乯尋媶巟墖暘扴丏
3. 帪栰棽帄丏椷榓俀擭搙丂嶥杫堛壢戝妛 摿掕堛妛尋媶悇恑帠嬈乮愭抂揑尋媶乯丏
4. 堜屗愳夒巎丏旕僐乕僪RNA偺敪尰僱僢僩儚乕僋夝愅偵婎偯偔徚壔婍娻昦懺偺夝柧偲恌抐帯椕傊偺墳梡丏暯惉31-椷榓俁擭搙暥晹壢妛徣壢妛尋媶旓曗彆嬥乮婎斦尋媶C乯尋媶戙昞丏
5. 堜屗愳夒巎丏擔杮恖儊儔僲乕儅摿桳偺堚揱巕曄堎傪昗揑偲偟偨帯椕朄偺奐敪丏戞35夞乮椷榓俀擭搙乯岞塿嵿抍朄恖庻尨婰擮嵿抍丆尋媶彆惉丏嫟摨尋媶幰丏
6. 扥壓 惓堦楴丏岥峯偑傫慻怐偵偍偄偰梊屻儅乕僇乕偲側傝偆傞PRC2峔惉抈敀幙偺婡擻扵嶕丏椷榓俀乣係擭搙暥晹壢妛徣壢妛尋媶旓曗彆嬥乮婎斦尋媶俠乯尋媶戙昞丏
7. 扥壓 惓堦楴丏梊屻晄椙側鋁憻娻偵偍偗傞怴婯梊屻儅乕僇乕堚揱巕偺婡峔夝柧丏椷榓俀擭搙 嬥戲戝妛偑傫恑揥惂屼尋媶強嫟摨尋媶丏尋媶戙昞.
8. 扥壓 惓堦楴丏峝偝偍傛傃埑弅巋寖偵墳摎偟偨鋁憻偑傫嵶朎偵偍偗傞堚揱巕敪尰曄摦僷僞乕儞偺栐梾夝愅丏椷榓俀擭搙 杒奀摴戝妛師悽戙尋媶幰儕乕僟乕堢惉嫟摨尋媶彆惉丏嫟摨尋媶幰.